On November 30, 2023, BrightPath Biotherapeutics Co., Ltd. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
57 JPY | 0.00% | -3.39% | -34.48% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
188.6 AUD | -0.75% | -0.80% | 46.59B | ||
57 JPY | 0.00% | -3.39% | 25.87M | ||
1st Jan change | Capi. | |
---|---|---|
-34.48% | 25.87M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- 4594 Stock
- News BrightPath Biotherapeutics Co., Ltd.
- BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited